TrialInvestigational new drugs2024

A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.

Daiki Tsuji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.